Action Research to Develop and Evaluate Interventions to Increase Access to BRCA1/BRCA2 plus Genetic Testing for hereditary Cancer in Health Region 6

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20260710020

Enrollment

Registered

2026-07-10

Start date

2026-07-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The study focuses on the following key aspects related to these conditions: BRCA1/BRCA2 Gene Mutations: The research centers on the screening and testing of these specific gene mutations in high-risk breast cancer patients. Hereditary Cancer Syndromes: Beyond breast cancer, the project examines access to services for patients with various types of hereditary cancers that can be identified through genetic testing. Cascade Testing in Relatives: The study also addresses the health of at-risk rel

Interventions

Service Process Optimization - Integrating genetic services into existing breast clinics and developing a one-stop service model to streamline the testing process. Technological Support - Implementing

Navigation - Utilizing telegenetics (remote counseling) and patient navigators to guide patients through the service pathway. Proactive Cascade Testing - Establishing an opt-in direct contact system w

Experimental Other

Package of Measures

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Provincial/Regional Policy Level: Individuals responsible for supervising, managing, or coordinating BRCA service policies within the Provincial Health Offices (PHO) or the National Health Security Office (NHSO) Region 6. 2) Healthcare Facility Level: Persons in charge of breast cancer clinics, medical records/IT, laboratories, or quality assurance at A/S/M1/M2 level hospitals located in Region 6. 3) Qualitative Aspect: Stakeholders involved throughout the entire service pathway (including service providers, patients/recipients, and their relatives) who provide informed consent to participate in accordance with ethical regulations

Exclusion criteria

Exclusion criteria: 1) Inability to provide informed consent for research participation. 2) Being in a condition where providing information is not possible, such as having a severe illness during the study period.

Design outcomes

Primary

Measure	Time frame
Process Outcomes Months 3-4 and 8-9 In-depth interviews & Focus Group Discussions (FGD), Service process mapping, Thematic and Framework analysis (using PRISM/RE-AIM),Operational Outcomes Months 6-8 and 8-9 Interviews and short questionnaires, Reflection notes and field notes, Service implementation data forms, Fidelity checklists and Adaptation logs,Quantitative Outcomes Months 3-4 and 8-9 Structured questionnaires (Set 1 for Policy level; Set 2 for Hospital level) using Likert scales, Descriptive statistics comparing pre- and post-intervention data	—

Measure

Time frame

Process Outcomes Months 3-4 and 8-9 In-depth interviews & Focus Group Discussions (FGD), Service process mapping, Thematic and Framework analysis (using PRISM/RE-AIM),Operational Outcomes Months 6-8 and 8-9 Interviews and short questionnaires, Reflection notes and field notes, Service implementation data forms, Fidelity checklists and Adaptation logs,Quantitative Outcomes Months 3-4 and 8-9 Structured questionnaires (Set 1 for Policy level; Set 2 for Hospital level) using Likert scales, Descriptive statistics comparing pre- and post-intervention data

—

Secondary

Measure	Time frame
Policy & Scale-up Outcomes Months 10-12 Qualitative synthesis of findings from all phases, Policy forums and stakeholder dialogues	—

Countries

Thailand

Contacts

Public ContactVaralak Srinonprasert

Mahidol University

varalaksi@gmail.com0800886024

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026